ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 10660 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 10660; 2) Community: the network communities that were significantly associated with the response to NSC 10660; 3) Molecule: the relationships between components within communities and NSC 10660; 4) MDR: the compounds that were significantly associated with the NSC 10660.

NSC Compound Enrichment Correlation
NSC 753664 Null 0.049093561024907 0.39516355
NSC 756188 GSK718429A 0.049093561024907 0.26766804
NSC 756406 GW852849X 0.049093561024907 0.27993673
NSC 756407 GW853606X 0.049093561024907 0.24852452
NSC 756413 GW876790X 0.049093561024907 0.23203257
NSC 7821 [6-(Dimethylamino)-3H-phenoxazin-3-ylidene]dimethylammonium chloride 0.049093561024907 -0.021013919
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.049093561024907 0.30935017
NSC 89671 Ascotoxin 0.049093561024907 -0.019189398
NSC 679005 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester 1.2187791866317e-005 0.36722485
NSC 720290 Methyl-7.alpha.,12.alpha.-Diacetoxy-5.beta.-cholan-24-oate-3 -spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 1.83022188098884e-005 0.30214766
Total:170  Current:168    [First] [Prev] [Next] [Last]